104 related articles for article (PubMed ID: 11340523)
1. Antifungal antibiotics and breakthrough bacteremias.
Wenzel RP; Gennings C; Edmond MB
Clin Infect Dis; 2001 Jun; 32(11):1538-9. PubMed ID: 11340523
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
3. Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients.
Viscoli C; Paesmans M; Sanz M; Castagnola E; Klastersky J; Martino P; Glauser M;
Clin Infect Dis; 2001 Jun; 32(11):1532-7. PubMed ID: 11340522
[TBL] [Abstract][Full Text] [Related]
4. [Medical care of fungal infection based on the Guidelines of the Infectious Diseases Society of America: Febrile neutropenia].
Sotoshima M
Jpn J Antibiot; 2012 Apr; 65(2):129-34. PubMed ID: 23038848
[No Abstract] [Full Text] [Related]
5. Febrile neutropenia: antifungal prophylaxis.
Donnelly JP
Int J Antimicrob Agents; 2000 Oct; 16(2):127-30. PubMed ID: 11053793
[TBL] [Abstract][Full Text] [Related]
6. [Empirical antifungal therapy in patients with febrile neutropenia].
Nucci M
Drugs Today (Barc); 2010 Apr; 46 Suppl C():13-20. PubMed ID: 20490378
[TBL] [Abstract][Full Text] [Related]
7. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
8. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
9. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
Klastersky J
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
[TBL] [Abstract][Full Text] [Related]
10. Treatment of febrile neutropenia with cefepime monotherapy.
Jándula BM; Martino R; Gurgi M; Manteiga R; Sierra J
Chemotherapy; 2001; 47(3):226-31. PubMed ID: 11306793
[TBL] [Abstract][Full Text] [Related]
11. Wait and see or rush and switch? New questions for the management of patients with febrile neutropenia receiving antifungal prophylaxis.
Karthaus M; Hentrich M
Mycoses; 2011 Jan; 54 Suppl 1():1-6. PubMed ID: 21126265
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial prophylaxis in febrile neutropenia.
Yoshida M; Ohno R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
Link H; Böhme A; Cornely OA; Höffken K; Kellner O; Kern WV; Mahlberg R; Maschmeyer G; Nowrousian MR; Ostermann H; Ruhnke M; Sezer O; Schiel X; Wilhelm M; Auner HW; ;
Ann Hematol; 2003 Oct; 82 Suppl 2():S105-17. PubMed ID: 13680173
[TBL] [Abstract][Full Text] [Related]
14. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
Kern WV; Beyer J; Böhme A; Buchheidt D; Cornely O; Einsele H; Kisro J; Krüger W; Maschmeyer G; Ruhnke M; Schmidt CA; Schwartz S; Szelenyi H;
Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1582-8. PubMed ID: 11199452
[No Abstract] [Full Text] [Related]
15. [Use of antifungal combination therapy].
Perez Diaz CE
Drugs Today (Barc); 2010 Apr; 46 Suppl C():47-50. PubMed ID: 20490382
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
[TBL] [Abstract][Full Text] [Related]
17. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
[TBL] [Abstract][Full Text] [Related]
18. [Specific antifungal treatment in patients with neutropenia and fever: current status of the fungicidal activity of caspofungin].
Finquelievich J
Drugs Today (Barc); 2010 Apr; 46 Suppl C():21-5. PubMed ID: 20490379
[TBL] [Abstract][Full Text] [Related]
19. [Fungal infections in oncohematology: the role of prophylaxis].
Sobrevilla Calvo P
Drugs Today (Barc); 2010 Apr; 46 Suppl C():7-11. PubMed ID: 20490377
[TBL] [Abstract][Full Text] [Related]
20. Antifungal prophylaxis and the rate of bacteremia among neutropenic patients.
Viscoli C; Paesmans M;
Clin Infect Dis; 2002 Jan; 34(2):289-91. PubMed ID: 11740722
[No Abstract] [Full Text] [Related]
[Next] [New Search]
